Screener
GeneDx Holdings WGS Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from GeneDx Holdings’s reported figures.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Other revenue | 955 | 1,356 |
| Total revenue | 102,254 | 87,115 |
| Cost of services | 34,043 | 28,639 |
| Gross profit | 68,211 | 58,476 |
| Research and development | 19,804 | 12,577 |
| Selling, general and administrative | 74,591 | 50,450 |
| Impairment loss | 31,287 | — |
| Loss from operations | (57,471) | (4,551) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's gross profit?
- GeneDx Holdings (WGS) reported gross profit of $68.21M in Q1 2026.
- How has GeneDx Holdings's gross profit changed year-over-year?
- GeneDx Holdings's gross profit increased by 16.6% year-over-year, from $58.48M to $68.21M.
- What is the long-term trend for GeneDx Holdings's gross profit?
- Over 4 years (2021 to 2025), GeneDx Holdings's gross profit has grown at a 105.9% compound annual growth rate (CAGR), from -$16.6M to $298.17M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about GeneDx Holdings's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude